Dr. Tchang is an Assistant Professor of Clinical Medicine at Weill Cornell Medicine. She is passionate about obesity as a medical disease and a social misunderstanding. Dr. Tchang's first priority is providing evidence-based weight management therapies to patients. Her second priority is sharing the latest science in nutrition, exercise, and pharmaceutical research to educate clinicians and expand a trusted network of obesity medicine specialists.
I worry more that people who do not have obesity or diabetes are buying semaglutide (which is sold under the brand names Wegovy and Ozempic, among others) at its out-of-pocket cost to get skinnier, likely stirred on by TikTok videos or Variety articles.
A dangerous weight loss trend is causing a shortage of insulin for diabetic patients.